Zobrazeno 1 - 10
of 30
pro vyhledávání: '"J N Barker"'
Autor:
A. Y. Finlay, J. N. Barker, A. D. Burden, C. E. M. Griffiths, B. Kirby, M. L. Goodman, C. Neill, R. B. Warren
Publikováno v:
JEADV Clinical Practice, Vol 1, Iss 3, Pp 207-218 (2022)
Abstract Background The Family Dermatology Life Quality Index (FDLQI) was developed to meet a need for a dermatology‐specific family member/partner quality‐of‐life (QoL) measure. This paper focuses on the analysis and interpretation of FDLQI da
Externí odkaz:
https://doaj.org/article/885e1faf40d14c64a60a1ef0cf072503
Autor:
M. D. Lynch, C. N. S. Lynch, E. Craythorne, K. Liakath-Ali, R. Mallipeddi, J. N. Barker, F. M. Watt
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-11 (2017)
Deep sequencing technologies allow for the investigation of clonal evolution in human cancers. Here the authors, combining sequencing data from human skin with mathematical modelling and simulations, suggest that the spatial context of a mutation wit
Externí odkaz:
https://doaj.org/article/0f0d3a09923e4b6eb97e3107824208bf
Autor:
John Bowes, Badbir study groups, Catherine H. Smith, Pauline Ho, Nick Dand, J. N. Barker, Farideh Jalalinajafabadi, A. Barton, Richard B. Warren, N. McHugh
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background Approximately 30% of patients with psoriasis develop a chronic inflammatory arthritis referred to as psoriatic arthritis (PsA). The ability to accurately predict which psoriasis patients will develop PsA would enable early intervention and
Autor:
P M, Laws, A M, Downs, R, Parslew, B, Dever, C H, Smith, J N, Barker, B, Moriarty, R, Murphy, B, Kirby, A D, Burden, S, McBride, A V, Anstey, S, O'Shea, N, Ralph, C, Buckley, C E M, Griffiths, R B, Warren
Publikováno v:
The British journal of dermatology. 166(1)
There are limited data on the use of ustekinumab outside of clinical trials.To assess the efficacy and safety of ustekinumab in patients with severe psoriasis attending 10 dermatology centres in the U.K. and Ireland.A retrospective case-note review o
Autor:
J N Barker, M L Jones, C L Swenson, V Sarma, R S Mitra, P A Ward, K J Johnson, J C Fantone, V M Dixit, B J Nickoloff
Publikováno v:
The Journal of Immunology. 146:1192-1197
Monocytes accumulate in the epidermis and along the dermo-epidermal junction in several different inflammatory skin diseases. To determine whether human epidermal keratinocytes elaborate a specific chemotaxin responsible for the accumulation of monoc
Publikováno v:
Clinical and experimental dermatology. 26(6)
The use of combination oral therapies in the management of severe psoriasis is gaining increasing acceptance. We report the concurrent use of mycophenolate mofetil (MMF) (maximum dose 3.0 g daily) with low-dose cyclosporin (mean dose 2.5 mg/kg/day) i
Publikováno v:
Clinical and experimental dermatology. 26(5)
Reduced bone mineral density (BMD), the major risk factor for osteoporotic fracture, has been linked to palmoplantar pustular psoriasis, but no significant studies have examined BMD in chronic plaque psoriasis (CPP). In this study, in-patients with s
Autor:
J N, Barker
Publikováno v:
Clinical and experimental dermatology. 26(4)
Epidemiological studies indicate that genes play an important role in the pathogenesis of psoriasis. Multiple genes are likely to be involved, interacting not only with each other but also with the environment to cause disease expression. Molecular g
Publikováno v:
Clinical and experimental dermatology. 25(8)
Exorex is a new topical formulation for the treatment of psoriasis; it contains 1% coal tar and a synthetic analogue resembling components identified in banana skin (a complex of esterified essential fatty acids). To determine whether the esterified
Publikováno v:
Clinical and experimental dermatology. 25(2)
Pustular psoriasis is a rare but serious form of psoriasis. Clinically it may be difficult to differentiate from a pustular drug reaction. We report a case of a generalized pustular eruption triggered by exposure to amoxycillin in a patient with chro